Evidence map›Paper›PMID 38138883›Full record

ArticleJournal of personalized medicine2023

Parental Understanding of Their Child's Germline Genomic Testing: Intent of Disclosure to Their Child and Family.

Belinda N Mandrell, Alise K Blake, Katianne M Howard Sharp, Jami S Gattuso, Rose B McGee, Lynn Harrison, Annastasia Ouma, Mary Caples, Liza-Marie Johnson, Kim E Nichols

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Belinda N MandrellDivision of Nursing Research, Department of Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-6041-7559
Alise K BlakeDivision of Cancer Predisposition, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Katianne M Howard SharpDepartment of Psychology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Jami S GattusoDivision of Nursing Research, Department of Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Rose B McGeeDivision of Cancer Predisposition, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Lynn HarrisonDivision of Cancer Predisposition, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Annastasia OumaDivision of Cancer Predisposition, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Mary CaplesDivision of Nursing Research, Department of Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Liza-Marie JohnsonDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Kim E NicholsDivision of Cancer Predisposition, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.ORCID 0000-0002-5581-6555
St. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

Genomic testing is becoming increasingly common in the care of pediatric patients with cancer. Parental understanding of germline results and their intent and timing of results disclosure to their child and family may have significant implications on the family unit. The purpose of this study was to examine parental understanding of germline genomic results and plans for disclosure to their child and other relatives. Semi-structured interviews were conducted with 64 parents of children with cancer, approximately eight weeks after parents had received their child's results. Parents of children with negative results (n = 20), positive results (n = 15), or variants of uncertain significance (n = 29), were interviewed. Fifty-three parents (83%) correctly identified their child's results as negative, uncertain, or positive. Most parents had disclosed results to family members; however, only 11 parents (17%) acknowledged discussing results with their child. Most parents delayed disclosure due to the young age of their child at the time of testing. In summary, most parents appropriately described their child's germline genomic results, yet few discussed the results with their child due to age. Families should be followed with supportive counseling to assist parents in the timing and content of result disclosure to their children.

Indexed as

disclosure of resultsgenomic sequencingknowledgepediatric cancer

Identifiers

PMID38138883
PMCPMC10744428
OpenAlexW4389085805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.